Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.5850
- TODAY'S CHANGE (%)-0.0450 (-1.2397%)
- Bid / Lots3.5800/ 21
- Ask / Lots3.5900/ 9
- Open / Previous Close3.6100 / 3.6300
- Day Range
- 52 Week Range
- Volume673,333
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 12481 | 3.65 |
| 09:34 ET | 3647 | 3.54 |
| 09:36 ET | 5395 | 3.585 |
| 09:38 ET | 977 | 3.59 |
| 09:39 ET | 2288 | 3.6 |
| 09:41 ET | 678 | 3.59 |
| 09:43 ET | 4081 | 3.56 |
| 09:45 ET | 200 | 3.55 |
| 09:48 ET | 340 | 3.55 |
| 09:50 ET | 1735 | 3.55 |
| 09:52 ET | 689 | 3.55 |
| 09:54 ET | 200 | 3.55 |
| 09:56 ET | 351 | 3.555 |
| 09:57 ET | 2318 | 3.565 |
| 09:59 ET | 1800 | 3.565 |
| 10:01 ET | 5469 | 3.62 |
| 10:03 ET | 1400 | 3.62 |
| 10:06 ET | 150 | 3.6121 |
| 10:08 ET | 5040 | 3.61 |
| 10:10 ET | 630 | 3.6 |
| 10:12 ET | 2843 | 3.59 |
| 10:14 ET | 200 | 3.595 |
| 10:15 ET | 600 | 3.6 |
| 10:17 ET | 400 | 3.595 |
| 10:19 ET | 857 | 3.585 |
| 10:21 ET | 1487 | 3.59 |
| 10:24 ET | 1898 | 3.57 |
| 10:26 ET | 1314 | 3.575 |
| 10:28 ET | 100 | 3.575 |
| 10:30 ET | 1193 | 3.57 |
| 10:32 ET | 3663 | 3.58 |
| 10:33 ET | 884 | 3.575 |
| 10:35 ET | 900 | 3.575 |
| 10:37 ET | 1400 | 3.605 |
| 10:39 ET | 1000 | 3.61 |
| 10:42 ET | 1851 | 3.595 |
| 10:44 ET | 1160 | 3.59 |
| 10:46 ET | 100 | 3.595 |
| 10:48 ET | 3196 | 3.58 |
| 10:50 ET | 8232 | 3.585 |
| 10:51 ET | 1600 | 3.58 |
| 10:53 ET | 35035 | 3.6 |
| 10:55 ET | 2390 | 3.595 |
| 10:57 ET | 5851 | 3.585 |
| 11:00 ET | 1500 | 3.585 |
| 11:02 ET | 4250 | 3.585 |
| 11:04 ET | 1000 | 3.585 |
| 11:06 ET | 3750 | 3.585 |
| 11:08 ET | 5455 | 3.585 |
| 11:09 ET | 7334 | 3.575 |
| 11:11 ET | 1258 | 3.575 |
| 11:13 ET | 2060 | 3.56 |
| 11:15 ET | 1300 | 3.56 |
| 11:18 ET | 2751 | 3.56 |
| 11:20 ET | 2129 | 3.575 |
| 11:22 ET | 700 | 3.585 |
| 11:24 ET | 1400 | 3.595 |
| 11:26 ET | 2719 | 3.5999 |
| 11:27 ET | 200 | 3.595 |
| 11:29 ET | 16302 | 3.595 |
| 11:31 ET | 1532 | 3.595 |
| 11:33 ET | 1727 | 3.605 |
| 11:36 ET | 800 | 3.605 |
| 11:38 ET | 905 | 3.605 |
| 11:40 ET | 100 | 3.605 |
| 11:42 ET | 300 | 3.61 |
| 11:44 ET | 1900 | 3.61 |
| 11:45 ET | 1719 | 3.605 |
| 11:47 ET | 300 | 3.6 |
| 11:49 ET | 2890 | 3.6 |
| 11:51 ET | 760 | 3.595 |
| 11:54 ET | 600 | 3.595 |
| 11:56 ET | 650 | 3.5968 |
| 11:58 ET | 100 | 3.6 |
| 12:00 ET | 4841 | 3.605 |
| 12:02 ET | 400 | 3.605 |
| 12:03 ET | 433 | 3.61 |
| 12:05 ET | 100 | 3.605 |
| 12:07 ET | 1000 | 3.615 |
| 12:09 ET | 3089 | 3.59 |
| 12:16 ET | 200 | 3.59 |
| 12:18 ET | 100 | 3.595 |
| 12:20 ET | 400 | 3.595 |
| 12:21 ET | 500 | 3.595 |
| 12:23 ET | 1470 | 3.5982 |
| 12:25 ET | 700 | 3.595 |
| 12:27 ET | 200 | 3.595 |
| 12:30 ET | 7199 | 3.595 |
| 12:32 ET | 3300 | 3.595 |
| 12:34 ET | 3654 | 3.595 |
| 12:36 ET | 2400 | 3.595 |
| 12:39 ET | 400 | 3.595 |
| 12:41 ET | 1790 | 3.585 |
| 12:43 ET | 500 | 3.585 |
| 12:45 ET | 300 | 3.585 |
| 12:48 ET | 1120 | 3.585 |
| 12:50 ET | 2509 | 3.585 |
| 12:52 ET | 100 | 3.58 |
| 12:54 ET | 100 | 3.585 |
| 12:56 ET | 2481 | 3.6 |
| 12:57 ET | 200 | 3.595 |
| 01:01 ET | 210 | 3.595 |
| 01:03 ET | 1900 | 3.58 |
| 01:06 ET | 100 | 3.585 |
| 01:08 ET | 2790 | 3.58 |
| 01:10 ET | 100 | 3.585 |
| 01:12 ET | 200 | 3.585 |
| 01:14 ET | 600 | 3.585 |
| 01:15 ET | 1400 | 3.58 |
| 01:17 ET | 3090 | 3.585 |
| 01:19 ET | 2656 | 3.575 |
| 01:21 ET | 300 | 3.57 |
| 01:24 ET | 6925 | 3.555 |
| 01:26 ET | 700 | 3.555 |
| 01:28 ET | 100 | 3.55 |
| 01:30 ET | 200 | 3.555 |
| 01:33 ET | 2090 | 3.55 |
| 01:35 ET | 400 | 3.555 |
| 01:37 ET | 4395 | 3.54 |
| 01:39 ET | 2449 | 3.53 |
| 01:44 ET | 100 | 3.535 |
| 01:46 ET | 1000 | 3.535 |
| 01:48 ET | 500 | 3.535 |
| 01:50 ET | 200 | 3.535 |
| 01:51 ET | 2533 | 3.53 |
| 01:53 ET | 200 | 3.535 |
| 01:55 ET | 200 | 3.54 |
| 01:57 ET | 475 | 3.535 |
| 02:00 ET | 5575 | 3.545 |
| 02:02 ET | 600 | 3.54 |
| 02:08 ET | 1789 | 3.555 |
| 02:09 ET | 100 | 3.555 |
| 02:11 ET | 151 | 3.56 |
| 02:13 ET | 899 | 3.56 |
| 02:15 ET | 1201 | 3.565 |
| 02:18 ET | 1100 | 3.565 |
| 02:20 ET | 2224 | 3.5505 |
| 02:22 ET | 100 | 3.555 |
| 02:24 ET | 100 | 3.55 |
| 02:26 ET | 489 | 3.55 |
| 02:27 ET | 1600 | 3.56 |
| 02:29 ET | 1190 | 3.555 |
| 02:31 ET | 400 | 3.56 |
| 02:33 ET | 3482 | 3.56 |
| 02:36 ET | 300 | 3.555 |
| 02:38 ET | 30618 | 3.555 |
| 02:40 ET | 6300 | 3.55 |
| 02:42 ET | 100 | 3.55 |
| 02:44 ET | 300 | 3.555 |
| 02:45 ET | 1000 | 3.555 |
| 02:47 ET | 3300 | 3.575 |
| 02:49 ET | 365 | 3.58 |
| 02:51 ET | 3100 | 3.57 |
| 02:54 ET | 400 | 3.575 |
| 02:56 ET | 200 | 3.58 |
| 02:58 ET | 1501 | 3.58 |
| 03:00 ET | 2778 | 3.585 |
| 03:02 ET | 500 | 3.585 |
| 03:03 ET | 1079 | 3.5805 |
| 03:05 ET | 708 | 3.585 |
| 03:07 ET | 300 | 3.585 |
| 03:09 ET | 2131 | 3.595 |
| 03:12 ET | 400 | 3.6 |
| 03:14 ET | 3368 | 3.585 |
| 03:16 ET | 300 | 3.58 |
| 03:18 ET | 1276 | 3.58 |
| 03:20 ET | 200 | 3.58 |
| 03:21 ET | 1436 | 3.575 |
| 03:23 ET | 938 | 3.58 |
| 03:25 ET | 200 | 3.575 |
| 03:27 ET | 3292 | 3.585 |
| 03:30 ET | 1120 | 3.585 |
Sep 19, 2024
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow JonesPress Release: Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 965.9M | -3.1x | --- |
Cullinan Therapeutics Inc | 970.5M | -5.4x | --- |
IGM Biosciences Inc | 981.1M | -3.9x | --- |
Sana Biotechnology Inc | 925.5M | -3.7x | --- |
Praxis Precision Medicines Inc | 1.0B | -5.6x | --- |
Applied Therapeutics Inc | 976.2M | -5.6x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $965.9M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-1.16 |
Book Value | --- |
P/E Ratio | -3.1x |
Price/Sales (TTM) | 92.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,775.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
